Mark Cuban Critiques PBM Profits, Advocates for Healthcare Transparency
LinkedIn
|
Contributed by: Bill Russell
Summary
Graham Walker, MD, expressed his excitement about an interview with Eric Topol, MD, and Mark Cuban, focusing on Cuban's critical views of Pharmacy Benefit Managers (PBMs) and their profit-driven rebate system, which complicates healthcare expenses for sick employees. He credits Eric Bricker, MD, for illuminating the financial complexities of PBMs and encourages healthcare executives, especially those from self-insured companies, to watch the full interview for clarity. Additionally, Walker highlights Cuban's Cost Plus Drug Company, which operates efficiently with a small team to manufacture sterile injectables at an 8.5% markup, addressing the current supply shortages.
